Literature DB >> 24381421

Oxidative stress and its relationship with adenosine deaminase activity in various stages of breast cancer.

Mridula Mahajan1, Nitika Tiwari1, Ritu Sharma1, Sukhraj Kaur1, Neetirajan Singh2.   

Abstract

Reactive oxygen species (ROS) cause damage to the DNA producing mutations and formation of tumours such as carcinoma of breast. Tumour cells are known to produce ROS at a greater pace than the non-transformed cells. The increased production of reactive oxygen species causes oxidative stress leading to cell proliferation and hence increased inflammatory conditions. The present study was aimed to investigate the role of oxidative stress in the pathogenesis of breast cancer. Females suffering from breast cancer had significantly decreased Superoxide dismutase (SOD) and reduced glutathione (GSH) levels in comparison to normal females. The compromised antioxidant defence system produces the oxidative stress which in turn creates the inflammatory response shown by concomitant increased adenosine deaminase (ADA) activity in female patients. ADA diminishes the protective molecule adenosine. There were significant variations (p < 0.01) in ADA activity with different clinical stages (stage 1-4) of breast cancer suggesting thereby that estimation of ADA activity can be used as a diagnostic tool to detect the stage of cancer along with cytological studies. Mastectomy was performed and post-operatively serum SOD and ADA activity and plasma GSH levels were estimated. There was a statistically significant increase in activity of SOD and levels of GSH while serum ADA activity decreased significantly, suggesting thereby that oxidative stress is responsible for increased cell proliferation and hence the inflammatory conditions in CA breast that got ameliorated post-operatively.

Entities:  

Keywords:  Adenosine deaminase; Breast cancer; GSH; SOD

Year:  2012        PMID: 24381421      PMCID: PMC3547448          DOI: 10.1007/s12291-012-0244-5

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  16 in total

1.  Improved method for the determination of blood glutathione.

Authors:  E BEUTLER; O DURON; B M KELLY
Journal:  J Lab Clin Med       Date:  1963-05

Review 2.  Benign breast diseases: classification, diagnosis, and management.

Authors:  Merih Guray; Aysegul A Sahin
Journal:  Oncologist       Date:  2006-05

Review 3.  Nucleotide metabolism and cell-cell interactions.

Authors:  Holger K Eltzschig; Thomas Weissmüller; Alice Mager; Tobias Eckle
Journal:  Methods Mol Biol       Date:  2006

Review 4.  Early breast cancer.

Authors:  John R Benson; Ismail Jatoi; Martin Keisch; Francisco J Esteva; Andreas Makris; V Craig Jordan
Journal:  Lancet       Date:  2009-04-25       Impact factor: 79.321

5.  Adenosine-mediated inhibition of the cytotoxic activity and cytokine production by activated natural killer cells.

Authors:  Anna Lokshin; Tatiana Raskovalova; Xiaojun Huang; Lefteris C Zacharia; Edwin K Jackson; Elieser Gorelik
Journal:  Cancer Res       Date:  2006-08-01       Impact factor: 12.701

6.  Adenosine deaminase activity in the serum and malignant tumors of breast cancer: the assessment of isoenzyme ADA1 and ADA2 activities.

Authors:  Mahmood Aghaei; Fatemeh Karami-Tehrani; Siamak Salami; Morteza Atri
Journal:  Clin Biochem       Date:  2005-10       Impact factor: 3.281

Review 7.  Oxidative mechanisms in carcinogenesis.

Authors:  K Z Guyton; T W Kensler
Journal:  Br Med Bull       Date:  1993-07       Impact factor: 4.291

8.  Serum biochemical markers in carcinoma breast.

Authors:  Late R K Seth; Simmi Kharb; D P Kharb
Journal:  Indian J Med Sci       Date:  2003-08

9.  Serum adenosine deaminase, 5'-nucleotidase & alkaline phosphatase in breast cancer patients.

Authors:  M Walia; M Mahajan; K Singh
Journal:  Indian J Med Res       Date:  1995-06       Impact factor: 2.375

10.  Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.

Authors:  Matthew E Mealiffe; Renee P Stokowski; Brian K Rhees; Ross L Prentice; Mary Pettinger; David A Hinds
Journal:  J Natl Cancer Inst       Date:  2010-10-18       Impact factor: 13.506

View more
  11 in total

1.  A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell Carcinoma.

Authors:  Kunpeng Du; Jingwen Zou; Baiyao Wang; Chunshan Liu; Muhammad Khan; Tao Xie; Xiaoting Huang; Piao Shen; Yunhong Tian; Yawei Yuan
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

2.  Quercetin reduces Ehrlich tumor-induced cancer pain in mice.

Authors:  Cassia Calixto-Campos; Mab P Corrêa; Thacyana T Carvalho; Ana C Zarpelon; Miriam S N Hohmann; Ana C Rossaneis; Leticia Coelho-Silva; Wander R Pavanelli; Phileno Pinge-Filho; Jefferson Crespigio; Catia C F Bernardy; Rubia Casagrande; Waldiceu A Verri
Journal:  Anal Cell Pathol (Amst)       Date:  2015-08-13       Impact factor: 2.916

3.  Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.

Authors:  Marcio S Medeiros; Arthur Schumacher-Schuh; Andreia Machado Cardoso; Guilherme Vargas Bochi; Jucimara Baldissarelli; Aline Kegler; Daniel Santana; Carolina Maria Martins Behle Soares Chaves; Maria Rosa Chitolina Schetinger; Rafael Noal Moresco; Carlos R M Rieder; Michele Rechia Fighera
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

4.  Twenty‑four signature genes predict the prognosis of oral squamous cell carcinoma with high accuracy and repeatability.

Authors:  Jianyong Gao; Gang Tian; Xu Han; Qiang Zhu
Journal:  Mol Med Rep       Date:  2017-12-12       Impact factor: 2.952

5.  Specific protein carbonylation in human breast cancer tissue compared to adjacent healthy epithelial tissue.

Authors:  Baikuntha Aryal; V Ashutosh Rao
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

6.  Changes of adenosine deaminase activity in serum and saliva around parturition in sows with and without postpartum dysgalactia syndrome.

Authors:  Marianne Kaiser; Jan Dahl; Stine Jacobsen; Magdalena Jacobson; Pia Haubro Andersen; Poul Bækbo; Damián Escribano; José Joaquín Cerón; Fernando Tecles
Journal:  BMC Vet Res       Date:  2021-11-18       Impact factor: 2.741

7.  Suppression of Adenosine Deaminase and Xanthine Oxidase Activities by Mineralocorticoid and Glucocorticoid Receptor Blockades Restores Renal Antioxidative Barrier in Oral Contraceptive-Treated Dam.

Authors:  Olufunto O Badmus; Emmanuel D Areola; Eleojo Benjamin; Matthew A Obekpa; Tolulope E Adegoke; Oluwatobi E Elijah; Aminu Imam; Olayemi J Olajide; Lawrence A Olatunji
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021-05-18       Impact factor: 1.636

8.  Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor-dependent mechanisms.

Authors:  Barbara Kutryb-Zajac; Patrycja Koszalka; Paulina Mierzejewska; Alicja Bulinska; Magdalena A Zabielska; Karolina Brodzik; Aleksandra Skrzypkowska; Lukasz Zelazek; Iwona Pelikant-Malecka; Ewa M Slominska; Ryszard T Smolenski
Journal:  J Cell Mol Med       Date:  2018-10-05       Impact factor: 5.310

Review 9.  Purine-Metabolising Enzymes and Apoptosis in Cancer.

Authors:  Marcella Camici; Mercedes Garcia-Gil; Rossana Pesi; Simone Allegrini; Maria Grazia Tozzi
Journal:  Cancers (Basel)       Date:  2019-09-12       Impact factor: 6.639

10.  Characterization of total adenosine deaminase activity (ADA) and its isoenzymes in saliva and serum in health and inflammatory conditions in four different species: an analytical and clinical validation pilot study.

Authors:  María Dolores Contreras-Aguilar; Asta Tvarijonaviciute; Ingrida Monkeviciene; María Martín-Cuervo; Luis Guillermo González-Arostegui; Lorena Franco-Martínez; José Joaquín Cerón; Fernando Tecles; Damián Escribano
Journal:  BMC Vet Res       Date:  2020-10-12       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.